Kamila Valieva — A Fifteen-Year-Old, a Banned Heart Drug, and an Adult System That Failed Her

Summary

Kamila Valieva was fifteen years old when she skated at the 2022 Beijing Winter Olympics, and fifteen when a sample she had given six weeks earlier was revealed, mid-Games, to contain a banned heart medication. On January 29, 2024, the Court of Arbitration for Sport found that she had committed an anti-doping rule violation, imposed a four-year ban backdated to December 25, 2021, and disqualified all of her results from that date — including the Olympic team event in which she had skated for the Russian Olympic Committee. As a consequence, the ROC's team gold was lost: the International Skating Union re-ranked the event, elevating the United States to gold and Japan to silver.

The substance was trimetazidine, an anti-anginal drug that improves cardiac efficiency and is banned in sport. The sample was collected on December 25, 2021, at the Russian national championships by RUSADA. The result should have been processed in days. Instead the WADA-accredited Stockholm laboratory did not report the positive until February 8, 2022 — after Valieva had already helped the ROC win the team event in Beijing. The timing detonated the Games' most painful controversy, and it was a failure of the adult laboratory and reporting system, not of the child who had given the sample.

Because she was fifteen, Valieva was a "protected person" under the World Anti-Doping Code — a category created to shield minors, who cannot reasonably be held to an adult's standard of personal responsibility, and to direct scrutiny toward the coaches, doctors, and officials around them. A CAS ad hoc panel cited that status during the Games in allowing her to keep competing; the final ruling two years later still imposed the standard four-year sanction, holding that her protected status did not eliminate the consequence. But the question her case forced was never really about a teenager's culpability. It was about the system of adults that put a banned drug into the body of a child and then took six weeks to say so — and this dossier aims its scrutiny where it belongs, at the entourage and the institutions. The skater at the centre was a minor, the person the Code exists to protect.

Timeline

The Drug and the Delay

Trimetazidine is a prescription angina medication that helps the heart use oxygen more efficiently under stress. WADA prohibits it because that same metabolic effect can aid endurance, and it has no business in the system of a fifteen-year-old figure skater. Its presence in Valieva's December 25 sample was, in anti-doping terms, unambiguous: a banned substance, detected, triggering strict liability. What was deeply ambiguous — and what the case never satisfactorily resolved — was how it got there; the explanations offered on her behalf, including contamination through a family member's medication, were not accepted by CAS as proven.

The detail that turned a doping positive into an international crisis was the delay. The sample was taken on December 25, 2021; the Stockholm laboratory did not report the result until February 8, 2022 — a six-week lag the lab partly attributed to a COVID-related backlog, and which fell, catastrophically, across the start of the Olympics. By the time the positive surfaced, Valieva had already skated in and won the team event. The notification that should have kept her out of Beijing instead arrived in the middle of it. That is not a failure attributable to a teenager; it is a failure of the laboratory and reporting chain the adult anti-doping system is supposed to run on time.

The consequence was that a fifteen-year-old became the public face of a doping scandal in real time, before any tribunal had determined anything. A timely result would have meant a provisional suspension before the Games and a child kept out of the glare; instead the system's own slowness placed her in it, the harm of that exposure inflicted on the youngest and least powerful person in the chain.

A Protected Person in an Unprotected Position

The World Anti-Doping Code carves out a category called the "protected person" — broadly, an athlete under sixteen. It exists on a clear principle: a child cannot be held to the same standard of informed personal responsibility as an adult professional, because a child does not control her own training, diet, medication, or medical care. The people who do — coaches, team doctors, officials, the entourage — are where the Code intends responsibility and scrutiny to fall when a minor tests positive. The rule is, in effect, an instruction to look past the child and at the adults.

During the Games, that status did real work. When RUSADA lifted Valieva's provisional suspension and the IOC, WADA, and ISU appealed, the CAS ad hoc panel that allowed her to compete in the individual event leaned on two things: that she was a protected person, and that the laboratory's notification had been untimely through no fault of hers. The panel was not ruling that she had done nothing wrong; it was ruling that, on the eve of an irreversible event, a fifteen-year-old should not be summarily excluded over a positive she had no fair chance to contest, caused by a delay she had not created.

The final 2024 award took a harder line on consequence while leaving the principle intact. CAS found the violation established and applied the standard four-year sanction, reasoning that protected-person status mitigates fault and lowers the burden of explanation but does not, by itself, erase the disqualification of results or shorten the ban where no innocent source is proven. The outcome sat uneasily because of who absorbed it: the visible penalty landed on the child, while the adults who managed her — and who, under the logic of the protected-person rule, bore the real responsibility — remained in the background of the headlines. The Code points the scrutiny at the entourage. The cameras pointed at the fifteen-year-old.

The Five Factors

Aftermath

The four-year ban, backdated to December 25, 2021, runs through late December 2025 — expiring weeks before the 2026 Winter Olympics. Valieva's challenge to the award before the Swiss Federal Tribunal, on grounds including the proportionality of sanctioning a minor, was unsuccessful, leaving the CAS ruling in force. The skater who arrived in Beijing as the favourite for individual gold left it without a medal, having fallen repeatedly in a free skate performed under scrutiny no fifteen-year-old should have to bear.

The case reshaped the conversation around minors in sport more than the chemistry of testing. In June 2022 the ISU voted to raise the minimum age for senior international skating from fifteen to seventeen, phased in by 2024–25 ahead of the 2026 Olympics, so that athletes that young are not exposed to such pressure or risk at all. The protected-person rule survived the case but stood accused of protecting the wrong person in practice: the visible consequence fell on a child, while the adults who controlled her care — the people the rule was written to hold accountable — largely escaped the glare it shone on her.

Lessons

References

• Figure skater Kamila Valieva suspended four years for anti-doping rule violation: CAS International Olympic Committee (Olympics.com)
• ISU Statement: Olympic Winter Games Beijing 2022 Figure Skating Team Event – Final ranking confirmed International Skating Union
• Russian figure skater disqualified from 2022 Olympics in doping case verdict PBS NewsHour / Associated Press
• Beijing 2022 figure skaters receive team event Olympic medals during ceremony in Champions Park at Paris 2024 International Olympic Committee
• The CAS publishes the arbitral award issued in the proceedings involving RUSADA, the ISU, WADA and Kamila Valieva LawInSport